Comprehensive characterization of the N-glycosylation status of CD44s by use of multiple mass spectrometry-based techniques

Analytical and Bioanalytical Chemistry

Volumn 404, Issue 2, 2012, Pages 373-388

  Han, Huanhuan ^a   Stapels, Martha ^b   Ying, Wantao ^a   Yu, Yingqing ^b   Tang, Li ^a   Jia, Wei ^b   Chen, Weibin ^a,b   Zhang, Yangjun ^a   Qian, Xiaohong ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b WATERS CORPORATION   (United States)

Author keywords

CD44s; Liquid chromatography; Mass spectrometry; N glycosylation; Site specific

Indexed keywords

CD44S; CHEMICAL DERIVATIZATION; COMPLEX-TYPE GLYCANS; EXOGLYCOSIDASE; INTEGRATED STRATEGY; ISOFORMS; MALDI TOF MS; MICROENVIRONMENTS; N-GLYCAN; N-GLYCANS; N-GLYCOSYLATION; SITE-SPECIFIC; STABLE-ISOTOPE LABELING; STANDARD TYPE; TRANSMEMBRANE GLYCOPROTEINS;

ESTERIFICATION; GLYCOSYLATION; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

CHEMICAL ANALYSIS;

HERMES ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CONFERENCE PAPER; GLYCOSYLATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; TUMOR CELL CULTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; CHROMATOGRAPHY, LIQUID; GLYCOSYLATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR CELLS, CULTURED;

EID: 84865467601     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6167-4     Document Type: Conference Paper

References (50)

1. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164
2. Stamenkovic I, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-348
3. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
4. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW (1995) Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419-429
5. Borland G, Ross JA, Guy K (1998) Forms and functions of CD44. Immunology 93(2):139-148
6. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21:3949-3959
7. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with the extracellular matrix. Adv Immunol 54:271-335
8. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptorligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512
9. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB (1992) A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531
10. Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35-48
11. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893-904
12. Kawano Y, Okamoto I, Murakami D, Itoh H, Yoshida M, Ueda S, Saya H (2000) Ras oncoprotein induces CD44 cleavage through phosphoinositide 3-OH kinase and the rho family of small G proteins. J Biol Chem 275:29628-29635
13. Sneath RJ, Mangham DC (1998) The normal structure and function of CD44 and its role in neoplasia. Mol Pathol 51:191-200
14. Katoh S, Miyagi T, Taniguchi H, Matsubara Y, Kadota J, Tominaga A, Kincade PW, Matsukura S, Kohno S (1999) Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol 162:5058-5061
15. Lesley J, English N, Perschl A, Gregoroff J, Hyman R (1995) Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182:431-437
16. English NM, Lesley JF, Hyman R (1998) Site-specific de-Nglycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res 58:3736-3742
17. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199-1208
18. Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R (2000) A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci U S A 97:13841-13846
19. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K (2006) Variant isoforms of CD44 are P-and Lselectin ligands on colon carcinoma cells. FASEB J 20:337-339
20. Alves CS, Yakovlev S, Medved L, Konstantopoulos K (2009) Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin (ogen). J Biol Chem 284:1177-1189
21. Tang L, Yang J, Tang X, Ying W, Qian X, He F (2010) The DCSIGN family member LSECtin is a novel ligand of CD44 on activated T cells. Eur J Immunol 40:1185-1191
22. Skelton TP, Zeng C, Nocks A, Stamenkovic I (1998) Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 140:431-446
23. Chen M, Ying W, Song Y, Liu X, Yang B, Wu S, Jiang Y, Cai Y, He F, Qian X (2007) Analysis of human liver proteome using replicate shotgun strategy. Proteomics 7:2479-2488
24. Packer NH, Lawson MA, Jardine DR, Redmond JW (1998) A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj J 15:737-747
25. Morelle W, Michalski JC (2007) Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2:1585-1602
26. Ueda K, Takami S, Saichi N, Daigo Y, Ishikawa N, Kohno N, Katsumata M, Yamane A, Ota M, Sato TA, Nakamura Y, Nakagawa H (2010) Development of serumglycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes. Mol Cell Proteomics 9:1819-1828
27. Dai Z, Zhou J, Qiu SJ, Liu YK, Fan J (2009) Lectin-based glycoproteomics to explore and analyze hepatocellular carcinomarelated glycoprotein markers. Electrophoresis 30:2957-2966
28. Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, Smith RD (2005) Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 4:2070-2080
29. Shakey Q, Bates B, Wu J (2010) An approach to quantifying Nlinked glycoproteins by enzyme-catalyzed 18O-labeling of solidphase enriched glycopeptides. Anal Chem 82:7722-7728
30. Barinka C, Sácha P, Sklenár J, Man P, Bezouska K, Slusher BS (2004) Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. J Protein Sci 13:1627-1635
31. Atwood JA 3rd, Minning T, Ludolf F, Nuccio A, Weatherly DB, Alvarez-Manilla G, Tarleton R, Orlando R (2006) Glycoproteomics of Trypanosoma cruzi trypomastigotes using subcellular fractionation, lectin affinity, and stable isotope labeling. J Proteome Res 5:3376-3384
32. Angel PM, Lim JM, Wells L, Bergmann C, Orlando R (2007) A potential pitfall in 18O-based N-linked glycosylation site mapping. Rapid Commun Mass Spectrom 21:674-682
33. Morelle W, Donadio S, Ronin C, Michalski JC (2006) Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry. Rapid Commun Mass Spectrom 20:331-345
34. Whelan SA, Lu M, He J, Yan W, Saxton RE, Faull KF, Whitelegge JP, Chang HR (2009) Mass spectrometry (LC-MS-MS) sitemapping of N-glycosylated membrane proteins for breast cancer biomarkers. J Proteome Res 8:4151-4160
35. Cao J, Shen C, Wang H, Shen H, Chen Y, Nie A, Yan G, Lu H, Liu Y, Yang P (2009) Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach. J Proteome Res 8:662-672
36. Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H (2009) Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res 8:651-661
37. Muchmore EA, Milewski M, Varki A, Diaz S (1989) Biosynthesis of N-glycolyneuraminic acid-the primary site of hydroxylation of Nacetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem 264:20216-20223
38. Irie A, Suzuki A (1998) CMP-N-acetylneuraminic hydroxylase is exclusively inactive in humans. Biochem Biophys Res Commun 248:330-333
39. Wada Y, Azadi P, Costello CE, Dell A, Dwek RA, Geyer H, Geyer R, Kakehi K, Karlsson NG, Kato K, Kawasaki N, Khoo KH, Kim S, Kondo A, Lattova E, Mechref Y, Miyoshi E, Nakamura K, Narimatsu H, Novotny MV, Packer NH, Perreault H, Peter-Katalinic J, Pohlentz G, Reinhold VN, Rudd PM, Suzuki A, Taniguchi N (2007) Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 17:411-422
40. Wuhrer M, Deelder AM (2006) Matrix-assisted laser desorption/ionization in-source decay combined with tandem time-of-flight mass spectrometry of permethylated oligosaccharides: targeted characterization of specific parts of the glycan structure. Rapid Commun Mass Spectrom 20:943-951
41. Smargiasso N, De Pauw E (2010) Optimization of matrix conditions for the control of MALDI in-source decay of permethylated glycans. Anal Chem 82:9248-9253
42. Olivova P, Chen W, Chakraborty AB, Gebler JC (2008) Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flightmass spectrometry. Rapid Commun Mass Spectrom 22:29-40
43. Xie H, Gilar M, Gebler JC (2009) Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry. Anal Chem 81:5699-5708
44. Gilar M, Yu YQ, Ahn J, Xie H, Han H, Ying W, Qian X (2011) Characterization of glycoprotein digests with hydrophilic interaction chromatography and mass spectrometry. Anal Biochem 417:80-88
45. Huddleston MJ, Bean MF, Carr SA (1993) Collisional fragmentation of glycopeptides by electrospray ionization LC-MS and LC-MS-MS: methods for selective detection of glycopeptides in protein digests. Anal Chem 65:877-884
46. Schindler PA, Settineri CA, Collet X, Fielding CJ, Burlingame AL (1995) Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC-electrospray mass spectrometry and sequential glycosidase digestion. Protein Sci 4:791-803
47. Jebanathirajah J, Steen H, Roepstorff P (2003) Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning. J Am Soc Mass Spectrom 14:777-784
48. Bajorath J, Greenfield B, Munro SB, Day AJ, Aruffo A (1998) Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J Biol Chem 273:338-343
49. Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, Lowe E, Mahoney DJ, Tammi MI, Kahmann JD, Campbell ID, Day AJ, Jackson DG (2004) Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell 13:483-496
50. Rudd PM, Dwek RA (1997) Glycosylation: Heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol 32:1-100